by mallika.b.n m.sc mbhg 060149006
TRANSCRIPT
-
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
1/20
-
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
2/20
-
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
3/20
INTRODUCTION
"Statins" are a class of drugs that lowerthe level ofcholesterol in the blood by
reducing the production of cholesterol bythe liver
Scientifically, statins are referred to asHMG-CoA reductase inhibitors.
They also lower the concentrations ofplasma LDL and VLDL levels
http://www.medicinenet.com/script/main/art.asp?articlekey=320http://www.medicinenet.com/script/main/art.asp?articlekey=320 -
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
4/20
BACK
-
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
5/20
HISTORY
And the credit goes toAKIRA ENDO &MASAO KURODA
Started a project in 1971 to search for microbialmetabolites that inhibit HMG-CoAreductase
Implying plasma cholesterol reductions in humans
Led to the discovery of MEVASTATIN from
P.citrinum 1st statin approved for use in humans
LOVASTATIN (merck) from A.terreus
-
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
6/20
BACK
-
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
7/20
-
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
8/20
MECHANISM OF ACTION
Inhibit hepatic cholesterol synthesis
Increased expression of LDL receptor gene
Increased uptake of LDL from blood
-
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
9/20
-
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
10/20
-
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
11/20
-
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
12/20
ABSORPTION,
METABOLISM &
EXCRETION Administered orally & at bedtime
Intestinal absorption:- 30% - 85%
Administration:
1) Most of the statins- active form
2) simvastatin & lovastatin-inactive prodrugs Uptake by the liver:
1) Mediated by organic anion transporter 2 (OATP)
2) Simple diffusion
Liver biotransforms all statins & >70% statin metabolites are
excreted by the liver with subsequent elimination in the feces.
-
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
13/20
PLIEOTROPIC EFFECTS
OF STATIN
Statin therapy enhances endothelial production of
the vasodilator nitric oxide, leading to improved
endothelial function after a month of therapy Statins decreased the risk of CHD and levels of C-
reactive protein
). Statins reduce the susceptibility of lipoproteins
to oxidation both in vitro and ex vivo
STATINS & coagulation
-
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
14/20
Doug Peterson developed slurred speech,balance problems and severe fatigue afterthree years on Lipitor--for two and a halfyears, he had no side effects at all. Itbegan with restless sleep patterns--twitching and flailing his arms. Loss of
balance followed and the beginning ofwhat Doug calls the "statin shuffle"--aslow, wobbly walk across the room. Finemotor skills suffered next. It took himfive minutes to write four words, much ofwhich was illegible. Cognitive functionalso declined. It was hard to convince hisdoctors that Lipitor could be the culprit,but when he finally stopped taking it, his
coordination and memory improved.
My Husband had a cholesterol level of7. He was prescribed simvastatin 18months ago 40mg. Previously he hadmanaged to reduce his cholesterol toaround 6 by diet but it kept creeping upagain. Heart disease was a hereditary
factor in his family.Firstly after takingsimvastain, he suffered constipationand had slight pain in the groin and hiparea. He went to the Doctor who couldfind nothing wrong and eventuallyreduced his statin to 20mg. All theseailments disappeared but unfortunatelyhe has now been diagnosed with
prostate cancer. I believe thatsimvastatin is responsible for thisdiagnosis
-
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
15/20
ADVERSE EFFECTS
MILD UNWANTEDEFFECTS:
Gastrointestinal
disturbance Insomnia
Rashes
Increased plasmaconcentrations of liverenzymes
SERIOUS EFFECTS:
Rhabdomyolysis
Hepatotoxicity
-
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
16/20
CONCLUSION
-
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
17/20
-
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
18/20
STATIN IS ADVISABLE
Provided that the patients metabolic
response to statin is under surveillance
-
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
19/20
REFERENCES
Chapter 35: . drug therapy for hypercholesterolemiaand dyslipidemia -Robert W. Mahley and Thomas P.
Bersot
Essentials of medical pharmacology:K.D.Tripathi
Brodys human pharmacology- molecular toclinical- 4th ed- by minneman & wecker
medical pharmacology at a glace- 4thed;m.j neal
World wide web
-
8/14/2019 By Mallika.b.n m.sc Mbhg 060149006
20/20
NOT OVER YET